Skip to main content
logo
Adagio Medical Holdings, Inc. (ADGM)
NASDAQ: ADGM · Real-Time Price · USD
0.9702
+0.0163 (1.71%)
At close: Jan 9, 2026, 4:00 PM EST
0.9103
-0.0599 (-6.17%)
After-hours: Jan 9, 2026, 6:11 PM EST

Adagio Medical Holdings Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Adagio Medical Holdings stock has a target of 4.00, which predicts a 312.29% increase from the current stock price of 0.97.

Price Target: $4.00 (+312.29%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$4.00$4.00$4.00$4.00
Change+312.29%+312.29%+312.29%+312.29%
* Price targets were last updated on Dec 2, 2025.

Analyst Ratings

According to 1 stock analyst, the rating for Adagio Medical Holdings is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingJan '26
Strong Buy1
Buy0
Hold0
Sell0
Strong Sell0
Total1

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Frank Takkinen
Lake Street
Lake Street
Strong Buy
Initiates
$4
Strong BuyInitiates$4+312.29%Dec 2, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 602.00K
Revenue Next Year
n/a
EPS This Year
-1.70
from -11.22
EPS Next Year
-1.01
from -1.70
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
270.00K189.00K300.00K602.00K--1.84M
Revenue Growth
--30.00%58.73%100.67%---
EPS
-27.15-31.50-48.16-11.22-1.70-1.01-1.09
EPS Growth
-------
Forward PE
-------
No. Analysts
----333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue2025202620272028
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth2025202620272028
High--
Avg--
Low--

EPS Forecast

EPS2025202620272028
High-1.75-1.04
Avg-1.70-1.01
Low-1.64-0.97

EPS Growth

EPS Growth2025202620272028
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.